S&P 500 Daily Review 24AUG23 #stockmarket #stocks #shorts

Boston Scientific boosts PFA expectations, citing rapid Farapulse adoption

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 net sales: $4.21

October 23, 2024

Favorable Long-Term Results With Ranibizumab Implant for Neovascular AMD

The ranibizumab port delivery system (PDS; Susvimo) with 6-month refill maintained noninferiority to monthly intravitreal injections for neovascular age-related macular degeneration (nAMD) out to 2

July 8, 2023

bit.bio defends European patent for ‘novel’ opti-ox technology – Pharmaceutical Technology

The EPO ruling affirms bit.bio’s European patent for opti-ox, its proprietary stem cell engineering technology. Credit: Yavdat/ Shutterstock bit.bio has successfully defended the European patent

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.